← Eichor
Condition: Dgf Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Dgf

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Admin
Phase 3 · 130 location(s) · Alexion Pharmaceuticals, Inc. · NCT06830798The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients
Phase 1/Phase 2 · 2 location(s) · First Affiliated Hospital of Chongqing Medical University · NCT07275632MR-proADM as a Early Biomarker for DGF and AR in Kidney and Liver Transplantation
Phase N/A · 1 location(s) · University of Rome Tor Vergata · NCT06130046
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.